Targeting Antimicrobial Resistance in Salmonella Enteritidis:
Synergistic Action of N-acetyl cysteine with Florfenicol and CRISPR-Cas
System Involvement
Mehmood Ahmad *1, Muhammad Ovais Omer *1,
Zahid Iqbal 2, Adeel Sattar1 and Muhammad Abu
Bakr Shabbir 3
1
Department of Pharmacology and Toxicology, Faculty of Bio-Sciences,
University of Veterinary and Animal Sciences, Lahore, Pakistan;2
Department of Pharmacology and Toxicology, Faculty of Veterinary and
Animal Sciences, The Islamia University of Bahawalpur, Bahawalpur,
Pakistan; 3 Institute of Microbiology, University of
Veterinary and Animal Sciences, Lahore, Pakistan.
Salmonella enterica subsp. enterica serovar Enteritidis
(SE) is one of the significant public health threats, mainly due to the
emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR)
strains. Along with several known factors, such as irrational antibiotic use,
horizontal gene transfer, and the possible involvement of the CRISPR-Cas system,
these have necessitated the exploration of alternative treatment strategies. The
present study aimed to identify the antibiogram of SE isolates from poultry and
evaluate the synergistic effects of florfenicol (FF) and N-acetylcysteine (NAC)
against MDR SE as well as explore the interplay of the CRISPR-Cas system in the
emergence of AMR. Two hundred and seventy-one samples were collected. The
samples included both cloacal and fecal samples from poultry birds in the
Bahawalpur and Lahore Regions of Punjab, Pakistan. Identification and isolation
were performed through conventional bacteriological methods followed by PCR.
Phenotypic assays, including minimum inhibitory concentration (MIC), minimum
bactericidal concentration (MBC), mutant prevention concentration (MPC), and
fractional inhibitory concentration index (FICI), were performed. Genotypic
confirmation was performed by identifying AMR genes. Out of 271 samples, thirty
(n=30) were confirmed positive for SE with IE gene-based PCR. Results revealed
that the isolates were resistant against most of the antibiotics including,
(86.67%), AMP (96.67%), AMX (96.67%), CTX (83.33%), GEN (83.33%), CH (60%), CLI
(90%), TET (96.67%), SMZ/TMP (66.67%), VAN (56.67%), ENR (63.33%), CIP (53.33%),
and CO (96.67%). Conversely, FF was effective against 56.67% of isolates. All of
the resistant isolates (n = 30) exhibited the presence of antimicrobial
resistance genes, including mphA, aac(3)-IIa, tetA, Sul1, gyrA, floR, qnrA, and
mcr-1. The co-administration of NAC with FF demonstrated a significant
synergistic effect against XDR SE isolate and the MIC of FF was notably reduced
when combined with NAC (FICI; 0.2 to 0.5). Additionally, a significant (P<0.05)
downregulation of CRISPR-Cas 3 genes was also recorded through qRT-PCR in both
resistant and ATCC13076 strains after treatment with co-administration of FF and
NAC compared with isolates treated with FF alone. It was concluded that the
combination of NAC enhances the antimicrobial activity of FF, reduces biofilm
formation, and potentially mitigates the antimicrobial resistance associated
with the CRISPR-Cas system.
To Cite This Article:
Ahmad M, Omer MO, Iqbal Z, Sattar A and Shabbir MAB 2025.
Targeting antimicrobial resistance in
Salmonella enteritidis: synergistic action of n-acetyl cysteine with
florfenicol and CRISPR-Cas system involvement. Pak Vet J.
http://dx.doi.org/10.29261/pakvetj/2025.212